SB 2097

  • Tennessee Senate Bill
  • 112th Regular Session (2021-2022)
  • Introduced in Senate Feb 02, 2022
  • Senate
  • House
  • Governor

Insurance, Health, Accident - As introduced, requires certain insurers with policies or contracts that provide coverage for Veklury (remdesivir) to also provide coverage for monoclonal antibody infusions and budesonide treatment at a cost to the insured no greater than the cost of Veklury (remdesivir) to the insured on or after July 1, 2022. - Amends TCA Title 8; Title 56 and Title 71.

Votes


No votes to display

Actions


Feb 25, 2022

Senate

Withdrawn.

Senate

Recalled from Senate Commerce & Labor Committee

Feb 03, 2022

Senate

Passed on Second Consideration, refer to Senate Commerce and Labor Committee

Feb 02, 2022

Senate

Introduced, Passed on First Consideration

Jan 31, 2022

Senate

Filed for introduction

Bill Text

Bill Text Versions Format
Current Version PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Tennessee General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.